F. Charbonnier

Publications by Year

Research Areas

Genetic factors in colorectal cancer, Colorectal Cancer Treatments and Studies, Cancer-related Molecular Pathways, Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics

Most-Cited Works

• → Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy(2007)733 cited
• → A simple p53 functional assay for screening cell lines, blood, and tumors.(1995)451 cited
• → Segregation of a Missense Mutation in the Microtubule-Associated Protein Tau Gene with Familial Frontotemporal Dementia and Parkinsonism(1998)247 cited
• Detection of exon deletions and duplications of the mismatch repair genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments.(2000)
• → TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy(2009)84 cited
• Identification of novel germline hMLH1 mutations including a 22 kb Alu-mediated deletion in patients with familial colorectal cancer.(1996)
• → Detection of 11 germline inactivating TP53 mutations and absence of TP63 andHCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome(2001)75 cited
• → High frequency in esophageal cancers of p53 alterations inactivating the regulation of genes involved in cell cycle and apoptosis(2000)61 cited
• → Detection of heterozygousSMN1 deletions in SMA families using a simple fluorescent multiplex PCR method(2001)36 cited
• → Clinical interest of KRAS mutation detection in blood for anti-EGFR therapies in metastatic colorectal cancer(2008)34 cited